An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia

OBJECTIVE: To evaluate the cost-effectiveness of aripiprazole and olanzapine in patients with schizophrenia. METHODS: Data from a double-blind, randomized study demonstrating the efficacy of aripiprazole and olanzapine were used to observe new incidence of metabolic syndrome (26-week therapy) and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Giorgio L, Caruggi, Mauro, Di Matteo, Sergio, Rossi, Alessandro
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626916/
https://www.ncbi.nlm.nih.gov/pubmed/19183788

Ejemplares similares

Ejemplares similares